Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Li-Yan Gu
Increased Risk of Severe Infections in Cancer Patients Treated With Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Meta-Analysis
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Versus Bevacizumab in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
Vascular Endothelial Growth Factor Gene Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer
Clinical Genitourinary Cancer
Oncology
Urology
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients With Advanced Non-Small Cell Lung Cancer
Current Gerontology and Geriatrics Research
Gerontology
Geriatrics
Risk of Severe Hematologic Toxicities in Cancer Patients Treated With PARP Inhibitors: A Meta-Analysis of Randomized Controlled Trials
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients With Refractory Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
Increased Risk of Cerebrovascular Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis
PLoS ONE
Multidisciplinary
Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome
Archives of Rheumatology
Rheumatology
Cardiotoxicity Monitoring in Patients Treated With Tyrosine Kinase Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
